1. Home
  2. ACXP vs HXHX Comparison

ACXP vs HXHX Comparison

Compare ACXP & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

SELL

Current Price

$1.04

Market Cap

5.8M

Sector

Health Care

ML Signal

SELL

Logo Haoxin Holdings Limited Class A Ordinary Shares

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.17

Market Cap

4.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACXP
HXHX
Founded
2017
2003
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
4.7M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ACXP
HXHX
Price
$1.04
$0.17
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $17.00
N/A
AVG Volume (30 Days)
84.4K
★ 739.5K
Earning Date
11-12-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$1.96
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.12
52 Week High
$7.54
$1.36

Technical Indicators

Market Signals
Indicator
ACXP
HXHX
Relative Strength Index (RSI) 40.18 36.55
Support Level N/A N/A
Resistance Level $1.77 $0.22
Average True Range (ATR) 0.07 0.02
MACD 0.01 0.01
Stochastic Oscillator 48.53 43.78

Price Performance

Historical Comparison
ACXP
HXHX

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is a China-based logistics company engaged in temperature-controlled transportation and urban delivery services. The company provides cold chain logistics, freight forwarding, and related transportation services for goods, including new energy materials, electronic products, pharmaceuticals, meat, fruits, and vegetables. Its principal revenue streams are temperature-controlled truckload services and urban delivery services.

Share on Social Networks: